Evidence-Based Minireview: Full dose, modified dose, or no anticoagulation for patients with cancer and acute VTE and thrombocytopenia Review
| Authors: | Patell, R.; Zwicker, J. I. |
| Review Title: | Evidence-Based Minireview: Full dose, modified dose, or no anticoagulation for patients with cancer and acute VTE and thrombocytopenia |
| Abstract: | Co-incident venous thromboembolism and thrombocytopenia are frequent in patients with active malignancies. The optimal approach for anticoagulation in patients with cancer and thrombocytopenia is not established. Different strategies are often utilized including dose-reduced anticoagulation dictated by degree of thrombocytopenia or transfusing platelets in order to facilitate therapeutic anticoagulation. This minireview provides an overview of the data and we outline our approach toward anticoagulation in patients with venous thromboembolism and thrombocytopenia in the setting of cancer. Copyright © 2022 by The American Society of Hematology. |
| Keywords: | neoplasm; neoplasms; bleeding; thrombocytopenia; anticoagulants; venous thromboembolism; anticoagulant agent; complication; hemorrhage; humans; human |
| Journal Title: | Hematology-American Society of Hematology Education Program |
| Volume: | 2022 |
| Issue: | 1 |
| ISSN: | 1520-4391 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-12-09 |
| Start Page: | 312 |
| End Page: | 315 |
| Language: | English |
| DOI: | 10.1182/hematology.2022000411 |
| PUBMED: | 36485075 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Export Date: 3 January 2023 -- Source: Scopus |
